Medulloblastoma is the most common malignant embryonal tumor of the central nervous system in the pediatric population, although it may also occur in adults. Its management requires a multimodal approach including surgical resection, craniospinal radiotherapy, and chemotherapy, which have significantly improved overall survival. However, these treatments are associated with late complications, among which radiation-induced secondary neoplasms are particularly relevant. We present the case of a 60-year-old male with a history of infratentorial medulloblastoma treated in 2020 with surgical resection, radiotherapy, and chemotherapy, who remained under active surveillance. Four years later, contrast-enhanced magnetic resonance imaging with spectroscopy revealed a new supratentorial lesion involving the genu of the corpus callosum, suggestive of a high-grade glioma. The patient underwent a right pre- and post-coronal craniotomy, where a poorly defined, grayish, avascular lesion was identified and biopsied. Histopathological and immunohistochemical analyses confirmed a high-grade glioma of glial origin, distinct from the initial medulloblastoma, supporting the diagnosis of a radiation-induced secondary neoplasm. Although meningiomas are the most frequently reported secondary tumors following craniospinal irradiation, high-grade gliomas represent a rare but aggressive complication with significant prognostic implications. This case underscores the importance of long-term imaging follow-up in patients treated with radiotherapy and highlights the need for further research to better understand the mechanisms underlying radiation-induced tumorigenesis.
References
[1]
Ramaswamy, V., Remke, M., Bouffet, E., Bailey, S., Clifford, S.C., Doz, F., et al. (2016) Risk Stratification of Childhood Medulloblastoma in the Molecular Era: The Current Consensus. Acta Neuropathologica, 131, 821-831. https://doi.org/10.1007/s00401-016-1569-6
[2]
Taylor, M.D., Northcott, P.A., Korshunov, A., Remke, M., Cho, Y., Clifford, S.C., et al. (2011) Molecular Subgroups of Medulloblastoma: The Current Consensus. ActaNeuropathologica, 123, 465-472. https://doi.org/10.1007/s00401-011-0922-z
Neglia, J.P., Robison, L.L., Stovall, M., Liu, Y., Packer, R.J., Hammond, S., et al. (2006) New Primary Neoplasms of the Central Nervous System in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study. JNCI: Journal of the NationalCancerInstitute, 98, 1528-1537. https://doi.org/10.1093/jnci/djj411
[5]
Merchant, T.E., Pollack, I.F. and Loeffler, J.S. (2010) Brain Tumors across the Age Spectrum: Biology, Therapy, and Late Effects. SeminarsinRadiationOncology, 20, 58-66. https://doi.org/10.1016/j.semradonc.2009.09.005
[6]
Cahan, W.G., Woodard, H.Q., Higinbotham, N.L., Stewart, F.W. and Coley, B.L. (1948) Sarcoma in Irradiated Bone. Report of Eleven Cases. Cancer, 1, 3-29. https://doi.org/10.1002/1097-0142(194805)1:1<3::aid-cncr2820010103>3.0.co;2-7
[7]
Louis, D.N., Perry, A., Wesseling, P., Brat, D.J., Cree, I.A., Figarella-Branger, D., et al. (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: A Summary. Neuro-Oncology, 23, 1231-1251. https://doi.org/10.1093/neuonc/noab106
[8]
Sadetzki, S., Flint-Richter, P., Ben-Tal, T. and Nass, D. (2002) Radiation-Induced Meningioma: A Descriptive Study of 253 Cases. JournalofNeurosurgery, 97, 1078-1082. https://doi.org/10.3171/jns.2002.97.5.1078
[9]
Paulino, A.C., Mai, W.Y., Chintagumpala, M., Taher, A. and Teh, B.S. (2008) Radiation-Induced Malignant Gliomas: Is There a Role for Reirradiation? InternationalJournalofRadiationOncologyBiologyPhysics, 71, 1381-1387. https://doi.org/10.1016/j.ijrobp.2007.12.018
[10]
Minniti, G., Traish, D., Ashley, S., Gonsalves, A. and Brada, M. (2005) Risk of Second Brain Tumor after Conservative Surgery and Radiotherapy for Pituitary Adenoma: Update after an Additional 10 Years. The Journal of Clinical Endocrinology & Metabolism, 90, 800-804. https://doi.org/10.1210/jc.2004-1152
[11]
Bowers, D.C., Nathan, P.C., Constine, L., Woodman, C., Bhatia, S., Keller, K., et al. (2013) Subsequent Neoplasms of the CNS among Survivors of Childhood Cancer: A Systematic Review. The Lancet Oncology, 14, e321-e328. https://doi.org/10.1016/s1470-2045(13)70107-4
[12]
Hwang, K., Lee, K.S., Choe, G., Cho, B. and Kim, C. (2018) Secondary Glioblastoma after Treatment of Intracranial Germinoma-Would Radiation-Only Therapy Still Be Safe? Case Report. BMC Cancer, 18, Article No. 1119. https://doi.org/10.1186/s12885-018-5073-3
[13]
Armstrong, G.T., Liu, Q., Yasui, Y., Huang, S., Ness, K.K., Leisenring, W., et al. (2009) Long-Term Outcomes among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study. JNCI: JournaloftheNationalCancerInstitute, 101, 946-958. https://doi.org/10.1093/jnci/djp148
[14]
Turcotte, L.M., Whitton, J.A., Friedman, D.L., Hammond, S., Armstrong, G.T., Leisenring, W., et al. (2015) Risk of Subsequent Neoplasms during the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort. Journal of Clinical Oncology, 33, 3568-3575. https://doi.org/10.1200/jco.2015.60.9487
[15]
Trkova, K., Sumerauer, D., Bubenikova, A., Krskova, L., Vicha, A., Koblizek, M., et al. (2024) Clinical and Molecular Study of Radiation-Induced Gliomas. Scientific Reports, 14, Article No. 3118. https://doi.org/10.1038/s41598-024-53434-0
[16]
Seidel, C., Heider, S., Hau, P., Glasow, A., Dietzsch, S. and Kortmann, R. (2021) Radiotherapy in Medulloblastoma—Evolution of Treatment, Current Concepts and Future Perspectives. Cancers, 13, Article 5945.
[17]
https://doi.org/10.3390/cancers13235945
[18]
Ahmad, Z., Rahim, S., Abdul-Ghafar, J., Chundriger, Q. and Ud Din, N. (2023) Events in CNS Tumor Pathology Post-2016 WHO CNS: cIMPACT-NOW Updates and Other Advancements: A Comprehensive Review Plus a Summary of the Salient Features of 2021 WHO CNS 5. InternationalJournalofGeneralMedicine, 16, 107-127. https://doi.org/10.2147/ijgm.s394872
[19]
Horbinski, C., Berger, T., Packer, R.J. and Wen, P.Y. (2022) Clinical Implications of the 2021 Edition of the WHO Classification of Central Nervous System Tumours. NatureReviewsNeurology, 18, 515-529. https://doi.org/10.1038/s41582-022-00679-w
[20]
Weller, M., Wen, P.Y., Chang, S.M., Dirven, L., Lim, M., Monje, M., et al. (2024) Glioma. NatureReviewsDiseasePrimers, 10, Article No. 33. https://doi.org/10.1038/s41572-024-00516-y
[21]
Thomas, D.L. (2023) 2021 Updates to the World Health Organization Classification of Adult-Type and Pediatric-Type Diffuse Gliomas: A Clinical Practice Review. ChineseClinicalOncology, 12, Article 7. https://doi.org/10.21037/cco-22-120